398 related articles for article (PubMed ID: 23739150)
21. Renal function with use of a tenofovir-containing initial antiretroviral regimen.
Gallant JE; Moore RD
AIDS; 2009 Sep; 23(15):1971-5. PubMed ID: 19696652
[TBL] [Abstract][Full Text] [Related]
22. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
[TBL] [Abstract][Full Text] [Related]
23. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
24. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
[TBL] [Abstract][Full Text] [Related]
25. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
[TBL] [Abstract][Full Text] [Related]
27. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
Mocroft A; Kirk O; Reiss P; De Wit S; Sedlacek D; Beniowski M; Gatell J; Phillips AN; Ledergerber B; Lundgren JD;
AIDS; 2010 Jul; 24(11):1667-78. PubMed ID: 20523203
[TBL] [Abstract][Full Text] [Related]
28. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
[TBL] [Abstract][Full Text] [Related]
29. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy.
Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2011 Oct; 26(10):3224-9. PubMed ID: 21372250
[TBL] [Abstract][Full Text] [Related]
30. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.
Buchacz K; Brooks JT; Tong T; Moorman AC; Baker RK; Holmberg SD; Greenberg A;
HIV Med; 2006 Oct; 7(7):451-6. PubMed ID: 16925731
[TBL] [Abstract][Full Text] [Related]
32. Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
Winston A; Amin J; Mallon P; Marriott D; Carr A; Cooper DA; Emery S
HIV Med; 2006 Mar; 7(2):105-11. PubMed ID: 16420255
[TBL] [Abstract][Full Text] [Related]
33. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
Gupta SK; Anderson AM; Ebrahimi R; Fralich T; Graham H; Scharen-Guivel V; Flaherty JF; Fortin C; Kalayjian RC; Rachlis A; Wyatt CM
PLoS One; 2014; 9(3):e92717. PubMed ID: 24651857
[TBL] [Abstract][Full Text] [Related]
34. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.
Goicoechea M; Liu S; Best B; Sun S; Jain S; Kemper C; Witt M; Diamond C; Haubrich R; Louie S;
J Infect Dis; 2008 Jan; 197(1):102-8. PubMed ID: 18171292
[TBL] [Abstract][Full Text] [Related]
35. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
36. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
[TBL] [Abstract][Full Text] [Related]
37. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
Bedimo RJ; Westfall AO; Drechsler H; Vidiella G; Tebas P
Clin Infect Dis; 2011 Jul; 53(1):84-91. PubMed ID: 21653308
[TBL] [Abstract][Full Text] [Related]
38. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
Judd A; Boyd KL; Stöhr W; Dunn D; Butler K; Lyall H; Sharland M; Shingadia D; Riordan A; Gibb DM
AIDS; 2010 Feb; 24(4):525-34. PubMed ID: 20139752
[TBL] [Abstract][Full Text] [Related]
39. Acute kidney injury in hospitalized HIV-infected patients: a cohort analysis.
Lopes JA; Melo MJ; Viegas A; Raimundo M; Câmara I; Antunes F; Gomes da Costa A
Nephrol Dial Transplant; 2011 Dec; 26(12):3888-94. PubMed ID: 21543659
[TBL] [Abstract][Full Text] [Related]
40. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy.
Biagi M; Badowski M; Chiampas T; Young J; Vaughn P; Shicker L; Patel M
Int J STD AIDS; 2016 Aug; 27(9):808-11. PubMed ID: 26378193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]